QuantumPharm Inc.

02228.HK

Provides drug and material science R&D solutions and services using quantum physics-based first-principles calculation, AI, cloud computing, and robotic automation, serving pharmaceutical and material science companies globally and domestically. Recognized as a global leader in computational solid-state R&D services per the prospectus.

Filings

The documents are on HKEXnews; we link to the originals.

Matters the filing discloses

From the company’s latest filing; open a kind of matter to see how other companies disclosed it.

• Customer concentration
• Supplier concentration
• Overlapping customers and suppliers
• Connected or related major customers / suppliers
• Reliance on platforms, partners or licences
• Single product, business line or region
• Key long-term agreements
• Backlog and project economics
• Losses and path to profitability
• Net current liabilities or net liabilities
• Cash burn and runway
• Working capital: receivables, prepayments and cash cycle
• Preferred shares and fair-value liabilities
• Investments and fair-value assets
• Non-IFRS measures and adjustments
• Non-recurring gains and losses
• Related-party transactions and balances
• Material share-based payments
• Chapter 18C specialist technology